A Randomized, Double-blind, Multi-center, Phase III Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil Combination in Patients With Essential Hypertension Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy
Latest Information Update: 08 May 2023
At a glance
- Drugs Amlodipine/candesartan-cilexetil (Primary) ; Amlodipine
- Indications Essential hypertension
- Focus Registrational; Therapeutic Use
- Sponsors HK inno.N
- 03 May 2023 Status changed from recruiting to completed.
- 02 Mar 2015 New trial record